e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
220.18
-9.13 (-3.98%)
Official Closing Price
Updated: 4:10 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,890,425
Open
227.00
Bid (Size)
220.20 (200)
Ask (Size)
220.60 (100)
Prev. Close
229.31
Today's Range
217.86 - 227.24
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.98%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Top S&P500 movers in Monday's session
↗
Today 15:05 EST
Via
Chartmill
Flu Season's Here—This Dividend-Payer Controls the Shot Market
↗
Today 14:38 EST
Via
MarketBeat
Topics
Artificial Intelligence
Death
Performance
YTD
-4.0%
-4.0%
1 Month
-2.6%
-2.6%
3 Month
-4.3%
-4.3%
6 Month
+17.3%
+17.3%
1 Year
+22.3%
+22.3%
More News
Read More
Uncover the latest developments among S&P500 stocks in today's session.
↗
Today 12:35 EST
Via
Chartmill
26 Top Dividend Stocks to Buy and Hold in 2026
↗
Today 4:05 EST
Via
The Motley Fool
Topics
Intellectual Property
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment
↗
Today 3:40 EST
Via
Stocktwits
Take Warren Buffett's Advice: Don't Buy Any Stock in 2026 Unless It Passes This Test
↗
January 04, 2026
Via
The Motley Fool
Buying This Healthcare Stock Could Make You a Millionaire Retiree
↗
January 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Retirement
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings?
December 30, 2025
Via
StockStory
Topics
Stocks
Supply Chain
IGSB vs VCSH: Two Approaches to Short-Term Investment-Grade Credit
↗
December 30, 2025
Via
The Motley Fool
Topics
Bonds
ETFs
3 No-Brainer Dividend Stocks to Buy Right Now
↗
December 30, 2025
Via
The Motley Fool
Topics
ETFs
Retirement
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why a New $3 Million Bet on Pathward Stock Signals Confidence in a Bank Posting $7.87 EPS
↗
December 28, 2025
Via
The Motley Fool
Is AbbVie a Buy, Sell, or Hold in 2026?
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $50,000 in Right Now
↗
December 27, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
December 25, 2025
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Top 5 US Healthcare Stocks By Market Value
↗
December 24, 2025
Via
Stocktwits
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
December 23, 2025
Via
MarketMinute
Topics
Intellectual Property
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
↗
December 22, 2025
Via
The Motley Fool
Topics
Intellectual Property
3 Dividend Growth Stocks Analysts Are Upgrading for 2026
↗
December 21, 2025
Via
MarketBeat
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026
↗
December 19, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen.
↗
December 18, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 220.18
When was AbbVie last traded?
The last trade of AbbVie was at 01/05/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert